Land: Neuseeland
Sprache: Englisch
Quelle: Ministry for Primary Industries
cloprostenol
AgriHealth NZ Limited
cloprostenol
cloprostenol 0.25 g/litre
Endocrine agent (hormone)
ACVM Registered
2011-12-22
CYCLASE - LABEL – APRIL 2020 VIAL LABEL RESTRICTED VETERINARY MEDICINE KEEP OUT OF THE REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CYCLASE ® [20ML OR 100ML] Injectable solution Contains: cloprostenol (as sodium) 250 µg/mL [Syntex Logo] DOSAGE: In DIB-Synch and DIB-Synch Plus programs in cattle: 2mL For INDICATIONS, DOSAGE and WARNINGS: see enclosed leaflet Store below 25C, protected from light. Use within 30 days of opening the pack. Date of mixing with Novormon: Use or discard by: MANUFACTURER: Syntex S.A. www.syntexar.com NEW ZEALAND DISTRIBUTOR: [AgriHealth logo] AgriHealth NZ Ltd www.agrihealth.co.nz ACVM Registration No A10490 Batch No: Exp. Date: [label code] CYCLASE - LABEL – APRIL 2020 INDIVIDUAL CARTON RESTRICTED VETERINARY MEDICINE KEEP OUT OF THE REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CYCLASE ® [20ML OR 100ML] Injectable solution Contains: cloprostenol (as sodium) 250 µg/mL FOR LUTEOLYSIS OF FUNCTIONAL CORPORA LUTEA IN COWS, PIGS AND HORSES Complements use of the DIB-V (A10319) and DIB-h (A10832) progesterone inserts and Gonasyn (A10642) in DIB-Synch and DIB-CoSynch oestrus synchrony programs, and also Novormon eCG (A10641) in DIB-Synch Plus programs. Can be used as a diluent for Novormon eCG. [SYNTEX Logo] Manufactured by Syntax S.A. www.syntexar.com DISTRIBUTED BY [AGRIHEALTH LOGO] AGRIHEALTH NZ LTD WWW.AGRIHEALTH.CO.NZ Restricted Veterinary Medicine Registered pursuant to the ACVM Act 1997 No A10490 See www.foodsafety.govt.nz for registration conditions. [BARCODE] Batch: Expiry: CYCLASE - LABEL – APRIL 2020 INDICATIONS For luteolysis of functional corpora lutea in cows, sows and mares. Manipulation of oestrus cycles, treatment of retained foetal membranes, pyometra or chronic endometritis and induction of abortion and parturition in cows. DOSAGE In DIB-Synch and DIB-Synch Plus programs in cattle: 2mL ADMINISTRATION Administer by intramuscular or subcutaneous injection in the anterior half of the neck. Read the enclosed leaflet before use. CONTRAINDICATIONS Do not use in pr Lesen Sie das vollständige Dokument